Date published: 2026-1-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

p38 MAP Kinase Inhibitor (CAS 219138-24-6)

5.0(1)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
2-(4-Chlorophenyl)-4-(4-fluorophenyl)-5-pyridin-4-yl-1,2-dihydropyrazol-3-one
Application:
p38 MAP Kinase Inhibitor is a potent p38 MAP kinase inhibitor
CAS Number:
219138-24-6
Purity:
>95%
Molecular Weight:
365.8
Molecular Formula:
C20H13ClFN3O
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

A p38 MAP Kinase Inhibitor is a compound that selectively inhibits the activity of p38 mitogen-activated protein kinases, which are a class of enzymes involved in cellular responses to stress and inflammatory cytokines. These inhibitors are tools for dissecting the signaling pathways mediated by p38 MAPK, which include the regulation of proinflammatory cytokine production, apoptosis, and cell differentiation. Researchers employ p38 MAP Kinase Inhibitors to study their role in modulating the inflammatory response and to understand the molecular basis of diseases where p38 MAPK is implicated. By inhibiting p38 MAPK activity, researchers can explore the kinase′s contributions to cellular processes and its interactions with other signaling molecules.


p38 MAP Kinase Inhibitor (CAS 219138-24-6) References

  1. The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signaling.  |  Macdonald, A., et al. 2003. J Biol Chem. 278: 17775-84. PMID: 12621033
  2. Mycophenolic acid inhibits platelet-derived growth factor-induced reactive oxygen species and mitogen-activated protein kinase activation in rat vascular smooth muscle cells.  |  Park, J., et al. 2004. Am J Transplant. 4: 1982-90. PMID: 15575900
  3. Nitrofen induces a redox-dependent apoptosis associated with increased p38 activity in P19 teratocarcinoma cells.  |  Kling, DE., et al. 2005. Toxicol In Vitro. 19: 1-10. PMID: 15582350
  4. A voltage-driven switch for ion-independent signaling by ether-à-go-go K+ channels.  |  Hegle, AP., et al. 2006. Proc Natl Acad Sci U S A. 103: 2886-91. PMID: 16477030
  5. Identification of small signalling molecules promoting cardiac-specific differentiation of mouse embryonic stem cells.  |  Sachinidis, A., et al. 2006. Cell Physiol Biochem. 18: 303-14. PMID: 17170517
  6. The roles of c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) in aged pig oocytes.  |  Petrová, I., et al. 2009. J Reprod Dev. 55: 75-82. PMID: 19023183
  7. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.  |  Gao, Y., et al. 2013. Biochem J. 451: 313-28. PMID: 23398362
  8. Overexpression of MMP-7 Increases Collagen 1A2 in the Aging Kidney.  |  Oelusarz, A., et al. 2013. Physiol Rep. 1: PMID: 24273653
  9. Human neutrophils are targets to paracoccin, a lectin expressed by Paracoccidioides brasiliensis.  |  Ricci-Azevedo, R., et al. 2018. Inflamm Res. 67: 31-41. PMID: 29018875
  10. Effect of baicalin on GLUT4 expression and glucose uptake in myotubes of rats.  |  Fang, P., et al. 2018. Life Sci. 196: 156-161. PMID: 29459024
  11. Granulocyte-macrophage colony-stimulating factor receptor expression in clinical pain disorder tissues and role in neuronal sensitization.  |  Donatien, P., et al. 2018. Pain Rep. 3: e676. PMID: 30534627
  12. Baicalin ameliorates hepatic insulin resistance and gluconeogenic activity through inhibition of p38 MAPK/PGC-1α pathway.  |  Fang, P., et al. 2019. Phytomedicine. 64: 153074. PMID: 31473580
  13. Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.  |  Bottomly, D., et al. 2022. Cancer Cell. 40: 850-864.e9. PMID: 35868306

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

p38 MAP Kinase Inhibitor, 500 µg

sc-204157
500 µg
$163.00

p38 MAP Kinase Inhibitor, 5 mg

sc-204157A
5 mg
$1191.00